Support The Moscow Times!
Contribute today
My account
Signout
×
Sections
Home
Ukraine War
News
Opinion
Business
Arts and Life
Regions
Podcasts
Galleries
Newsletters
TMT Lecture Series
Archive
Multimedia projects
Mothers & Daughters
Generation P
News
Ukraine War
Regions
Business
Meanwhile
Opinion
Podcasts
Archive
RU
My account
Signout
Support The Moscow Times!
Contribute today
Articles by Sergey Klimenko
B2B: Parallel Import of Medicines: High Time or the Wrong Time?
Russia is still heavily dependent on foreign medicines.
B2B: Foreign Medical Device Manufacturers: Should You Stay or Should You Go?
Although the conditions for entering the market have been reshaped, the legislation is about to give investors tools they never had before.
B2B: User-Friendly Legal Interface for the Life Sciences Market
Quite often, when describing the situation with regulating a specific Russian industry, we could construct analogies with the world of software, where...